Publication | Closed Access

Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of β-catenin

Nuclear LocationOncologyGlutamine-fructose-6-phosphate Transaminase 2Serous Ovarian CancerMedicineCancer Cell BiologyCancer BiologyRadiation OncologyCancer MetabolismCell BiologyTumor BiologyEndocrine-related CancerOvarian Cancer